| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |